Human PAI1(Plasminogen Activator Inhibitor 1) ELISA Kit
中文名称：人纤溶酶原激活物抑制因子1(PAI1)酶联免疫吸附测定试剂盒
Price:
- 反应性： Human
- 检测范围： 0.16-10 ng/mL
- 灵敏度： 0.1 ng/mL
| 产品应用 | ELISA |
| 检测原理 | 本试剂盒采用双抗体夹心ELISA法。用抗人PAI1抗体包被于酶标板上，实验时样品（或标准品）中的人PAI1会与包被抗体结合。后依次加入生物素化的抗人PAI1抗体和辣根过氧化物酶标记的亲和素，抗人PAI1抗体与结合在包被抗体上的人PAI1结合，生物素与亲和素特异性结合而形成免疫复合物，游离的成分被洗去。加入显色底物(TMB)，TMB在辣根过氧化物酶的催化下呈现蓝色，加终止液后变成黄色。用酶标仪在450 nm波长处测OD值，PAI1浓度与OD450值之间呈正比，通过绘制标准曲线计算出样品中PAI1的浓度。 |
| 反应类型 | Sandwich-ELISA |
| 规格 |
96 T
/ 48 T
/ 96 T × 5
|
| 反应时间 | 3 h 30 min |
| 反应性 | Human |
| 检测方法 | 比色法;ELISA;夹心法 |
| 检测范围 | 0.16-10 ng/mL |
| 灵敏度 | 0.1 ng/mL |
| 样本体积 | 100 μL |
| 样本类型 | 血清、血浆或其他生物体液 |
| 特异性 | 可检测样本中的人PAI1，且与其它类似物无明显交叉反应 |
| 精密度 | 板内，板间变异系数均<10% |
| 回收率 | 80%-120% |
| 储存条件 | 2-8℃ |
| 有效期 | 12个月 |
| 数据处理 |
-
One-Year Outcomes for Depression and Anxiety in SLE Patients
IF: 4.700 -
Dynamic Changes in Adiponectin and Resistin Drive Remission of Cardiometabolic Risk Biomarkers in Individuals with Obesity Following Bariatric Surgery
IF: 4.600 -
Biomarkers of Prothrombotic State and Risk Assessment of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
IF: 2.700Journal： International Journal of Chronic Obstructive Pulmonary Disease (2024)Reactivity：HumanSample Type：Plasma -
ASSESSMENT OF COAGULATION FACTORS IN PATIENTS WITH SEVERE RHEUMATIC MITRAL STENOSIS IN SINUS RHYTHM WITH LEFT ATRIAL APPENDAGE INACTIVITY
IF: 2.500 -
High mobility group box 1 derived mainly from platelet microparticles exacerbates microvascular obstruction in no reflow
IF: 10.407 -
Association of Heparin-Like Effect, Factor VII/XIII Deficiency and?Fibrinolysis with Rebleeding Risk in Cirrhosis with Acute Variceal Bleeding
IF: 3.487 -
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
IF: 2.086 -
Correlation of Vitamin D3, PAI-1, and HCG Hormone in Pre- and Post-Menopausal in Babylon Province
Journal： Reports of Biochemistry and Molecular Biology (2022)PMID：35765537Reactivity：HumanSample Type：serum -
Dysregulation of the Lysophosphatidylcholine/Autotaxin/Lysophosphatidic Acid Axis in Acute-on-Chronic Liver Failure Is Associated With Mortality and Systemic Inflammation by Lysophosphatidic Acid–Dependent Monocyte Activation
IF: 17.425 -
Cardiovascular Risk Indices and Their Impact on Outcome in Patients with Hyperglycaemic Emergencies in a Nigerian Hospital
IF: 1.030Journal： JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION (2020)PMID：31973880Reactivity：HumanSample Type：Serum
实验操作视频
